evaluating a treatment for her2-positive metastatic breast cancer
Published 3 months ago • 9 plays • Length 14:00Download video MP4
Download video MP3
Similar videos
-
2:02
what treatments are available for her2-positive metastatic breast cancer?
-
1:29
poziotinib for her2-positive metastatic breast cancer
-
6:08
first-line treatment of her2-positive metastatic breast cancer
-
1:55
advances in treatments for her2-positive metastatic breast cancer
-
1:31
current treatment options for patients with her2-positive metastatic breast cancer
-
3:19
study of targeted therapy for her2-positive metastatic breast cancer
-
54:02
navigating shifts in the treatment landscape for metastatic her2-positive breast cancer
-
2:55
audio described: clinical trial tests nivolumab for patients with rare brain and spine cancers
-
8:40
first-line treatment of her2-positive metastatic breast cancer
-
1:29
tuxedo-1: trastuzumab deruxtecan for the treatment of her2-positive breast cancer brain metastases
-
1:47
treatment for metastatic breast cancer
-
4:27
study of immunotherapy combinations for patients with her2-positive metastatic breast cancer
-
7:30
#esmo21 expert video report on her2-positive metastatic breast cancer
-
8:49
case study: treating her2-positive metastatic breast cancer, part i
-
2:49
neratinib, trastuzumab fulvestrant for her2-mutant, hr , metastatic breast cancer
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
49:09
metastatic breast cancer forum 2018: her2-positive breast cancer | dana-farber cancer institute
-
0:53
tuxedo-1: t-dxd for patients with her2-positive breast cancer and brain metastasis
-
31:21
novel therapeutics for breast cancer: her2 and triple negative disease; new pathways, targets